MLYS
#1923
Mineralys Therapeutics, Inc. - Common Stock
25.6 0 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.58%
Monthly Change
-1.88%
6 month change
-11.11%
Year Change
-36.59%
Previous Close
26.0 1
Open
25.6 0
Low
25.6 0
High
25.6 0
Volume
127
Financials
- Market Capitalization 2.26 B
- Employee 76
- Founded 2019
- CEO N/A
- Website mineralystx.com
- Headquarter Pennsylvania, United States
- FIGI BBG00ZXN1GN3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1918 |  HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 39.21 USD | -1.66% | +3.02% | +10.33% | +26.89% | 2.28 B USD | ||
| 1920 |  OCUL Ocular Therapeutix, Inc. - Common Stock | 10.36 USD | -4.25% | -5.90% | +23.78% | -9.91% | 2.28 B USD | ||
| 1924 |  MESO Mesoblast Limited - American Depositary Shares | 17.44 USD | -4.07% | +3.81% | +21.79% | +33.64% | 2.26 B USD | ||
| 1941 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 20.86 USD | -3.38% | +12.39% | +34.23% | +15.57% | 2.20 B USD |
Frequently asked questions about Mineralys Therapeutics, Inc. Common Stock
What is the Mineralys Therapeutics, Inc. Common Stock stock price today?
The current price of Mineralys Therapeutics, Inc. Common Stock (MLYS) is 25.60. Over the past 24 hours, the stock has changed by -1.58%. Follow the MLYS chart for real-time price dynamics.
What is the stock ticker of Mineralys Therapeutics, Inc. Common Stock?
Mineralys Therapeutics, Inc. Common Stock trades under the ticker MLYS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Mineralys Therapeutics, Inc. Common Stock stock going up?
MLYS has changed by -0.31% over the last week, -1.88% over the last month, and -36.59% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Mineralys Therapeutics, Inc. Common Stock?
Mineralys Therapeutics, Inc. Common Stock currently has a market capitalization of 2.26 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Mineralys Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Mineralys Therapeutics, Inc. Common Stock reported earnings of -2.85 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Mineralys Therapeutics, Inc. Common Stock net income for the last quarter?
Mineralys Therapeutics, Inc. Common Stock reported net income of -241.07 M for the last quarter. The previous quarter showed -39.34 M, which means net income changed by -512.80%.
How many employees does Mineralys Therapeutics, Inc. Common Stock have?
As of the latest available data, Mineralys Therapeutics, Inc. Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Mineralys Therapeutics, Inc. Common Stock stock?
You can buy Mineralys Therapeutics, Inc. Common Stock (MLYS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Mineralys Therapeutics, Inc. Common Stock stock?
Investing in Mineralys Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MLYS chart and related analysis on metatrader.com as part of your research.